Abstract | PURPOSE: METHODS: RESULTS:
Drug-specific increased risks were observed for valproic acid in relation to NTDs [adjusted odds ratio (aOR), 9.7;, 95% confidence interval (CI), 3.4-27.5], OCs (aOR, 4.4; 95% CI, 1.6-12.2), HDs (aOR, 2.0; 95% CI, 0.78-5.3), and hypospadias (aOR. 2.4; 95% CI, 0.62-9.0), and for carbamazapine in relation to NTDs (aOR, 5.0; 95% CI, 1.9-12.7). Epilepsy history without AED use did not seem to increase risk. CONCLUSIONS:
Valproic acid, which current guidelines suggest should be avoided in pregnancy, was most notable in terms of strength and breadth of its associations. Carbamazapine was associated with NTDs, even after controlling for folic acid use. Sample sizes were still too small to adequately assess risks of less commonly used AEDs, but our findings support further study to identify lower risk options for pregnant women.
|
Authors | Martha M Werler, Katherine A Ahrens, Jaclyn L F Bosco, Allen A Mitchell, Marlene T Anderka, Suzanne M Gilboa, Lewis B Holmes, National Birth Defects Prevention Study |
Journal | Annals of epidemiology
(Ann Epidemiol)
Vol. 21
Issue 11
Pg. 842-50
(Nov 2011)
ISSN: 1873-2585 [Electronic] United States |
PMID | 21982488
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Copyright | Copyright © 2011 Elsevier Inc. All rights reserved. |
Chemical References |
- Anticonvulsants
- Carbamazepine
- Valproic Acid
|
Topics |
- Abnormalities, Drug-Induced
(epidemiology, etiology)
- Adolescent
- Adult
- Anticonvulsants
(administration & dosage, adverse effects)
- Carbamazepine
(administration & dosage, adverse effects)
- Epilepsy
(drug therapy)
- Female
- Humans
- Male
- Pregnancy
- Pregnancy Complications
(drug therapy)
- United States
(epidemiology)
- Valproic Acid
(administration & dosage, adverse effects)
- Young Adult
|